We are live on ! Find out more
BRTX icon

BioRestorative Therapies

11 hedge funds and large institutions have $184K invested in BioRestorative Therapies in 2026 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

1.03% less ownership

Funds ownership: 3.69%2.66% (-1%)

15% less funds holding

Funds holding: 1311 (-2)

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

52% less capital invested

Capital invested by funds: $383K → $184K (-$199K)

Holders
11
Holders Change
-2
Holders Change %
-15.38%
% of All Funds
0.14%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
4
Reduced
Closed
4
Calls
Puts
Net Calls
Net Calls Change

BRTX Hedge Fund Activity: Q1 2026 in Review

11 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in BioRestorative Therapies (BRTX) for Q1 2026, worth a combined $184K — down 52% from $383K a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of BRTX and 3 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 4 added.

The largest buyer was Citadel Advisors, adding an estimated $134K. The largest seller was DRW Securities, exiting entirely with an estimated $54.8K sold.

  • 11 institutional investors held BioRestorative Therapies (BRTX) as of Q1 2026, down from 13 in Q4 2025.
  • Funds reported $184K of BioRestorative Therapies stock for Q1 2026, down 52% quarter-over-quarter.
  • 3 funds opened new BioRestorative Therapies positions in Q1 2026 and 4 closed out, a net change of -1 holder.
  • The largest BioRestorative Therapies buyer in Q1 2026 was Citadel Advisors, an estimated $134K added.
  • The largest BioRestorative Therapies seller in Q1 2026 was DRW Securities, an estimated $54.8K sold.

Based on aggregated 13F filings for Q1 2026.